University of Leeds Featured PhD Programmes
John Innes Centre Featured PhD Programmes
University of Kent Featured PhD Programmes
Catalysis Hub Featured PhD Programmes
University College London Featured PhD Programmes
United Kingdom
Leeds×
10 miles

Pharmacy / Pharmaceutics PhD Projects, Programs & Scholarships in Leeds

We have 24 Pharmacy / Pharmaceutics PhD Projects, Programs & Scholarships in Leeds

  • Pharmacy / Pharmaceutics×
  • United Kingdom×
  • Leeds×
  • clear all
Order by 
Showing 1 to 10 of 24
  Visualising protein dynamics in protein aggregation
  Prof S E Radford, Dr D Brockwell
Application Deadline: 31 May 2019
Proteins perform a wide variety of functions essential for life. For many proteins, the ability to undergo conformational changes while maintaining their native folded structure is essential for their function.
  Visualising protein dynamics in protein aggregation
  Dr D Brockwell, Prof S E Radford
Application Deadline: 31 May 2019
Proteins perform a wide variety of functions essential for life. For many proteins, the ability to undergo conformational changes while maintaining their native folded structure is essential for their function.
  Novel prodrug anti-metastatic therapy for neuroblastoma
  Research Group: Institute of Cancer Therapeutics
  Dr R Falconer
Application Deadline: 30 April 2019
This is one of three new fully-funded PhD studentships in the new Institute of Cancer Therapeutics Doctoral Training Centre (ICT-DTC) at the University of Bradford.
  Development of stimuli-responsive metallosupramolecular architectures for sensing and/or delivery of medicine for the treatment of solid tumours
  Research Group: Chemistry and Biosciences
  Dr D Petty, Dr M Najafzadeh, Dr S Pike
Applications accepted all year round
Applications are invited for a new self-funded PhD opportunity in the School of Chemistry & Biosciences at the University of Bradford.
  The role of community pharmacists in developing and implementing deprescribing initiatives in primary care
  Dr D Alldred
Application Deadline: 26 April 2019
This is an exciting opportunity to undertake a PhD within the Yorkshire and Humber Patient Safety Translational Research Centre (Yorkshire and Humber PSTRC), a partnership between the University of Leeds and Bradford Teaching Hospitals Foundation Trust.
  Targeting addiction to a breast cancer metastasis survival pathway by inhibition of RAN GTPase
  Research Group: Institute of Cancer Therapeutics
  Dr S Shnyder, Prof M El-Tanani, Dr S Betmouni
Applications accepted all year round
Metastatic cancer is a major global health burden. Each year, eleven million new cases of cancer are diagnosed worldwide, including 5 million cases in industrialized countries.
  Ran GTPase as a potential novel therapeutic target in EMT transdifferentiation and breast cancer stem cell (BCSC) survival during metastatic development
  Research Group: Institute of Cancer Therapeutics
  Prof R Morgan, Prof M El-Tanani, Dr M Isreb, Dr M Najafzadeh
Applications accepted all year round
Breast cancer is the leading cause of cancer death in women worldwide. Accumulating evidence suggests that local disease recurrence and metastatic lesions, the major causes of patient mortality, are due to a subset of aggressive cells termed cancer stem cells (CSCs).
  Re-purposing established drugs for the resolution of pulmonary arterial hypertension (PAH)
  Research Group: Pharmacology and Experimental Therapeutics
  Dr T Nasim
Applications accepted all year round
Pulmonary arterial hypertension (PAH) is a devastating cardiovascular disorder which, if left untreated, leads to heart failure and death.
  Pharmaceutical cocrystallisation for improved medicines
  Research Group: Medicines Development and Pharmaceutical Sciences
  Dr V Vangala, Prof A Paradkar
Applications accepted all year round
Active pharmaceutical ingredients (APIs) are frequently delivered to the patients in the solid-state formulation. Yet, therapeutic effectiveness of a dosage form depends on the bioavailability, stability and also on the manufacturability of the dosage form.
  Identifying glucose-dependent mechanisms underlying risk factors for Alzheimer’s disease
  Research Group: Pharmacology and Experimental Therapeutics
  Dr R Williamson, Dr S McLean
Applications accepted all year round
Several risk factors for Alzheimer’s disease including diabetes and midlife obesity are age-dependent and have an obvious metabolic component resulting in impaired glucose metabolism.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.